The following pages include information relating to the admission to trading on the regulated market of Euronext in Paris and the distribution to the shareholders of Sequana of shares of Antalis International. Access to the information and documents contained on the following pages may be restricted in certain jurisdictions by applicable laws and regulations and only certain categories of persons may be authorised to access such information and documents. All persons residents outside France who wish to have access to the documents contained on the this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website; or require registration or approval for any acquisition of securities by them and observe such restrictions. No such registration or approval has been obtained outside France. Sequana and Antalis International assume no responsibility if there is any violation of applicable law and regulations by any person.

The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy or acquire any shares of Antalis International in any jurisdiction in which it is unlawful to make such an offer or solicitation, including in the United States. The securities referred to therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. Sequana and Antalis International do not intend to register any portion of the proposed offering in the United States or to conduct a public offering in the United States. Consequently, U.S. residents and persons physically present in the United States are not permitted to access the information in the following pages.

The information available in the following pages may not be accessed by persons located in Australia, Canada or Japan.

By accessing to the information available in the following pages, you confirm that you are in compliance, and agree to comply, with the restrictions described above.

I confirm I do not confirm